Loading
A phase 1/2 trial of Vididencel run by Mendus, completed.
Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia is a phase 1/2 interventional study registered as NCT01373515 by Mendus, with 12 participants enrolled, started 2011-04. Conditions recorded: Acute Myeloid Leukemia (AML) and Leukemic Dendritic Cell Vaccination. Interventions recorded: DCP-001.
Shares Vididencel, Mendus, Acute myeloid leukaemia and the tag pipeline.
Shares Vididencel, Mendus and the tag pipeline.
Shares Vididencel, Mendus and the tag pipeline.
Shares Mendus and the tag pipeline.
Shares Mendus and the tag pipeline.
Shares Mendus and the tag pipeline.
Shares Mendus and the tag pipeline.
Shares Acute myeloid leukaemia and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/